Related Experiment Video
Updated: Feb 13, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Evolution of indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients
Massimo Galia1, Francesco Agnello2, Gianvincenzo Sparacia1
1Department of Radiology, University of Palermo, Via XII Gennaio 1/g, 90141, Palermo, Italy.
Insights
Indeterminate nodules in cirrhotic patients rarely progress to hepatocellular carcinoma (HCC). Key predictors of HCC development include nodule size increase and hepatobiliary phase hypointensity on MRI.
Area of Science:
- Hepatology
- Radiology
- Oncology
Background:
- Cirrhosis increases hepatocellular carcinoma (HCC) risk.
- Indeterminate nodules on MRI require careful monitoring.
- Gadolinium-ethoxybenzyl-diethylenetriamine-pentacetic acid (Gd-EOB-DTPA)-enhanced MRI aids nodule characterization.
Purpose of the Study:
- To analyze the evolution of indeterminate hepatocellular nodules in cirrhotic patients.
- To identify predictors of HCC development using serial Gd-EOB-DTPA-enhanced MRI.
Main Methods:
- Retrospective analysis of 69 indeterminate nodules in 33 cirrhotic patients.
- Follow-up MRI for at least 2 years.
- Evaluation of nodule size, signal intensity, and clinical factors.
Main Results:
- Only 5/69 nodules progressed to HCC.
- Nodule size increase and hepatobiliary phase hypointensity were significant predictors of HCC development.
- HCC history was more frequent in nodules that became HCCs.
Conclusions:
- Indeterminate hepatocellular nodules in cirrhotic patients rarely develop into HCC.
- Hepatobiliary phase hypointensity shows a weak association with HCC development.
- Serial MRI is crucial for monitoring nodule changes.
Purpose:
To retrospectively analyze the evolution of indeterminate hepatocellular nodules in cirrhotic patients on serial Gd-EOB-DPTA-enhanced MRI, and to identify predictors of HCC development.
Materials And Methods:
This IRB approved study included 33 cirrhotic patients with 69 indeterminate hepatocellular nodules (mean diameter 1.1 cm) at baseline Gd-EOB-DPTA-enhanced MRI and a Gd-EOB-DPTA-enhanced-MRI follow-up of at least 2 years. Two radiologists evaluated size and signal intensity of each nodule at baseline and follow-up. Age, cirrhosis etiology, and HCC history were recorded. Data were compared between nodules that became HCCs at follow-up (HCC) and those that did not (no-HCC).
Results:
On follow-up, 5/69 nodules became HCCs and 64/69 showed indeterminate characteristics. HCC history was more frequently found in HCCs than in no-HCCs. Age, sex, and cirrhosis etiology were not significantly different between HCCs and no-HCCs. HCCs had a significantly greater baseline diameter and increase in size than no-HCCs. Hepatobiliary phase hypointensity was significantly more common in HCCs than in no-HCCs. Multivariate regression analysis showed that increase in size (OR 10.48; sensitivity, 100%; specificity, 81.2%; p < 0.001) and hepatobiliary phase hypointensity (OR 1.02; sensitivity, 100%; specificity, 78.1%; p < 0.001) was associated with HCC development.
Conclusion:
Indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients rarely became HCCs. Hepatobiliary phase hypointensity had a weak association with HCC development.
Related Concept Videos
The Evidence for Evolution
Indeterminate Products
Indeterminate Structure
Convergent Evolution
Statically Indeterminate Problem Solving
Indeterminate Forms and L’Hôpital’s Rule

